Zoetis (ZTS) Total Liabilities (2012 - 2026)
Zoetis (ZTS) posted quarterly Total Liabilities of $11.9 billion for Q1 2026, up 26.24% year-over-year from $9.4 billion in Q1 2025, and down 1.28% quarter-over-quarter from $12.1 billion in Q4 2025.
Zoetis (ZTS) Total Liabilities (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has reported Total Liabilities for 15 consecutive years, with $11.9 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Liabilities rose 26.24% year-over-year to $11.9 billion; the TTM figure through Mar 2026 stood at $11.9 billion (up 26.24% YoY), while the FY2025 annual figure was $12.1 billion, up 27.55% from the prior year.
- Total Liabilities retreated to $11.9 billion in Q1 2026 per ZTS's latest filing, from $12.1 billion in the prior quarter.
- Across five years, Total Liabilities topped out at $12.1 billion in Q4 2025 and bottomed at $9.0 billion in Q3 2022.
- Historically, Total Liabilities has averaged $9.7 billion across 5 years, with a median of $9.3 billion in 2023.
- Annual changes were most pronounced in 2023 — Total Liabilities retreated 11.66% — and 2025, when it grew 27.55%.
- Zoetis' Total Liabilities stood at $10.5 billion in 2022, then dropped by 11.66% to $9.3 billion in 2023, then increased by 1.85% to $9.5 billion in 2024, then rose by 27.55% to $12.1 billion in 2025, then decreased by 1.28% to $11.9 billion in 2026.
- Business Quant data shows ZTS's Total Liabilities at $11.9 billion in Q1 2026, $12.1 billion in Q4 2025, and $9.8 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | -21.66 Bn |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 32.10 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 11.93 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 50.85 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 819.80 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 20.78 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 1.67 Bn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 6.97 Bn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 2.12 Bn |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | 2.58 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.93 Bn |
| Mar 31, 2026 | 11.92 Bn |
| Dec 31, 2025 | 12.08 Bn |
| Sep 30, 2025 | 9.76 Bn |
| Jun 30, 2025 | 9.50 Bn |
| Mar 31, 2025 | 9.44 Bn |
| Dec 31, 2024 | 9.47 Bn |
| Sep 30, 2024 | 9.12 Bn |
| Jun 30, 2024 | 9.21 Bn |
| Mar 31, 2024 | 9.30 Bn |
| Dec 31, 2023 | 9.30 Bn |
| Sep 30, 2023 | 9.03 Bn |
| Jun 30, 2023 | 9.13 Bn |
| Mar 31, 2023 | 9.26 Bn |
| Dec 31, 2022 | 10.52 Bn |
| Sep 30, 2022 | 9.01 Bn |
| Jun 30, 2022 | 9.19 Bn |
| Mar 31, 2022 | 9.20 Bn |
| Dec 31, 2021 | 9.36 Bn |
| Sep 30, 2021 | 9.02 Bn |